Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Plasma Transfusion Dosing Algorithm in Chronic Liver Disease
NCT02366845Phase 4Completed
- Sponsor
- University of Colorado Denver
- Start
- Jun 2012
- Primary completion
- Jun 2015
- Modality
- Recombinant Proteins and Enzymes, Tissue Cells
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of fresh-frozen plasma in chronic liver disease (CLD), sponsored by University of Colorado Denver. Primary endpoint: Number of Participants That Reached Targeted International Normalized Ratio (INR) Within ±0.1 After First Fresh Frozen Plasma (FFP) Transfusion Completed. Started Jun 2012; status: completed.
02
Drugs
fresh-frozen plasma
03
Conditions
chronic liver disease (CLD)
Beyond the preview
Go deeper on NCT02366845.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02366845.